Sotac Pharma.

{
  "main_header": {
    "sid": 1003827,
    "name": "Sotac Pharma.",
    "stock_name": "Sotac Pharma.",
    "full_name": "Sotac Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/sotac-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "95.10",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "95.10",
    "mcapval": "105.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "SOTAC",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE0O2D01012",
    "curr_date": "Jul 23, 03:30 PM",
    "curr_time": "19:57 PM",
    "last_traded_at": "Jul 23, 03:30 PM IST",
    "bse_nse_vol": 2400,
    "exc_status": "Active",
    "traded_date": "Jul 23, 2026",
    "traded_date_str": "2026 07 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sotac-pharma-1003827-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sotac Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharmaceuticals-ltd-is-rated-strong-sell-4108903",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SotacPharmaceut_mojoScore_4108903.png",
        "date": "2026-07-20 10:10:58",
        "description": "Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharmaceuticals-ltd-is-rated-strong-sell-4093341",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SotacPharmaceut_mojoScore_4093341.png",
        "date": "2026-07-08 10:11:28",
        "description": "Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharmaceuticals-ltd-is-rated-strong-sell-4074842",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SotacPharmaceut_mojoScore_4074842.png",
        "date": "2026-06-27 10:10:48",
        "description": "Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 27 June 2026, providing investors with the most up-to-date perspective on the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4069106",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SotacPharmaceut_stocks_hitting_lower_circuit_4069106.png",
        "date": "2026-06-23 11:00:16",
        "description": "At Rs 105.45, sellers were still queuing — but there were no buyers willing to take the other side. Sotac Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 23 Jun 2026, with unfilled sell orders and a frozen price."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharmaceuticals-ltd-is-rated-sell-4055922",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SotacPharmaceut_mojoScore_4055922.png",
        "date": "2026-06-16 10:10:35",
        "description": "Sotac Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 May 2026. While the rating was revised on that date, the analysis below reflects the stock’s current position as of 16 June 2026, incorporating the latest fundamentals, returns, and financial metrics available today."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharmaceuticals-ltd-is-rated-sell-4026182",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SotacPharmaceut_mojoScore_4026182.png",
        "date": "2026-06-01 10:10:19",
        "description": "Sotac Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4019341",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SotacPharmaceut_valuationdot_4019341.png",
        "date": "2026-05-29 08:03:12",
        "description": "Sotac Pharmaceuticals Ltd has witnessed a significant shift in its valuation parameters, moving from a risky to a very attractive valuation grade. Despite a stagnant share price at ₹111.00, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case for investors seeking value within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharmaceuticals-ltd-is-rated-strong-sell-4002844",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SotacPharmaceut_mojoScore_4002844.png",
        "date": "2026-05-21 10:10:22",
        "description": "Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3987683",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SotacPharmaceut_stocks_hitting_upper_circuit_3987683.png",
        "date": "2026-05-12 14:00:07",
        "description": "At Rs 111.3, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Sotac Pharmaceuticals Ltd locked at its upper circuit of 5.0% on 12 May 2026, with buyers queuing and no sellers willing to part with shares."
      }
    ],
    "total": 340,
    "sid": "1003827",
    "stock_news_url": "https://www.marketsmojo.com/news/sotac-pharmaceuticals-1003827"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sotac Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sotac Pharmaceuticals Ltd is Rated Strong Sell

2026-07-20 10:10:58

Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Sotac Pharmaceuticals Ltd is Rated Strong Sell

2026-07-08 10:11:28

Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Sotac Pharmaceuticals Ltd is Rated Strong Sell

2026-06-27 10:10:48

Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 27 June 2026, providing investors with the most up-to-date perspective on the stock’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Sotac Pharmaceuticals Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight

2026-06-23 11:00:16

At Rs 105.45, sellers were still queuing — but there were no buyers willing to take the other side. Sotac Pharmaceuticals Ltd locked at its lower circuit of 5.0% on 23 Jun 2026, with unfilled sell orders and a frozen price.

Read full news article

Sotac Pharmaceuticals Ltd is Rated Sell

2026-06-16 10:10:35

Sotac Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 May 2026. While the rating was revised on that date, the analysis below reflects the stock’s current position as of 16 June 2026, incorporating the latest fundamentals, returns, and financial metrics available today.

Read full news article

Sotac Pharmaceuticals Ltd is Rated Sell

2026-06-01 10:10:19

Sotac Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 27 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Sotac Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-05-29 08:03:12

Sotac Pharmaceuticals Ltd has witnessed a significant shift in its valuation parameters, moving from a risky to a very attractive valuation grade. Despite a stagnant share price at ₹111.00, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case for investors seeking value within the Pharmaceuticals & Biotechnology sector.

Read full news article

Sotac Pharmaceuticals Ltd is Rated Strong Sell

2026-05-21 10:10:22

Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Jan 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Sotac Pharmaceuticals Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent

2026-05-12 14:00:07

At Rs 111.3, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Sotac Pharmaceuticals Ltd locked at its upper circuit of 5.0% on 12 May 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

View All News